# Immuneering Corp — Form D

Immuneering Corp of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2019-10-04. The offering totals $15.0M, of which $15.0M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2019-10-04
- Form: D
- Accession: 0001567619-19-019273
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $15.0M
- Amount sold: $15.0M
- Investors: 49
- Date of first sale: 2019-09-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-350433

## Issuer

- Name: Immuneering Corp
- CIK: 0001790340
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 245 MAIN STREET, SECOND FLOOR, CAMBRIDGE, MA, 02142
- Phone: 617-500-8080

## Officers, directors & promoters (9)

| Name | Role | Location |
| --- | --- | --- |
| Benjamin J Zeskind | Director | Cambridge, MA |
| Benjamin J Zeskind | Executive Officer | Cambridge, MA |
| Laurie B Keating | Director | Cambridge, MA |
| Robert J Carpenter | Director | Cambridge, MA |
| Thomas J Schall | Director | Cambridge, MA |
| Diana F Hausman | Director | Cambridge, MA |
| Peter J Feinberg | Director | Cambridge, MA |
| Andrew J Phillips | Director | Boulder, CO |
| Joseph J Kekst | Director | CAMBRIDGE, MA |

## Other filings by this issuer (3)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2025-09-09](https://search.stillhousedata.com/formd/0001790340-25-000105) | D | $25.0M | $25.0M |
| [2021-01-05](https://search.stillhousedata.com/formd/0001567619-21-000199) | D | $62.0M | $37.2M |
| [2020-01-27](https://search.stillhousedata.com/formd/0001567619-20-001539) | D/A | $20.0M | $20.0M |

## More

- [CIK 1790340 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1790340&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001567619-19-019273.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.